Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PAR1 anticorps (Extracellular, N-Term)

F2R Reactivité: Humain WB, IHC, FACS, ICC, IF, LCI Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7043073
  • Antigène Voir toutes PAR1 (F2R) Anticorps
    PAR1 (F2R) (Coagulation Factor II (thrombin) Receptor (F2R))
    Épitope
    • 15
    • 15
    • 8
    • 7
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 61-76, Extracellular, N-Term
    Reactivité
    • 68
    • 25
    • 23
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Humain
    Hôte
    • 61
    • 7
    • 2
    Lapin
    Clonalité
    • 64
    • 6
    Polyclonal
    Conjugué
    • 39
    • 7
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp PAR1 est non-conjugé
    Application
    • 60
    • 36
    • 13
    • 13
    • 10
    • 8
    • 8
    • 5
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunofluorescence (IF), Live Cell Imaging (LCI)
    Réactivité croisée (Details)
    Unlikely to recognize mouse or rat samples.
    Attributs du produit
    Anti-Human PAR1 (F2R) (extracellular) Antibody (ABIN7043073, ABIN7045102 and ABIN7045103)) is a highly specific antibody directed against an epitope of human protease-activated receptor-1. The antibody can be used in western blot, immunohistochemistry, immunocytochemistry, and live cell flow cytometry applications. It has been designed to recognize PAR-1 from human samples.
    Purification
    Affinity purified on immobilized antigen.
    Immunogène

    Immunogen: Synthetic peptide

    Immunogen Sequence: (C)KNESGLTEYRLVSINK, corresponding to amino acid residues 61-76 of human PAR-1

    Isotype
    IgG
    Top Product
    Discover our top product F2R Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.
    Concentration
    0.8 mg/mL
    Buffer
    Reconstituted antibody contains phosphate buffered saline (PBS), pH 7.4, 1 % BSA, 0.05 % Sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    RT,4 °C,-20 °C
    Stockage commentaire

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Antigène
    PAR1 (F2R) (Coagulation Factor II (thrombin) Receptor (F2R))
    Autre désignation
    PAR1 (F2R) (F2R Produits)
    Synonymes
    anticorps CF2R, anticorps HTR, anticorps PAR-1, anticorps PAR1, anticorps TR, anticorps Par1, anticorps TRGPC, anticorps AI482343, anticorps Cf2r, anticorps ThrR, anticorps Par-1, anticorps f2r-a, anticorps par1, anticorps coagulation factor II thrombin receptor, anticorps coagulation factor II (thrombin) receptor, anticorps coagulation factor 2 (thrombin) receptor L homeolog, anticorps F2R, anticorps F2r, anticorps f2r.L
    Sujet
    Alternative names: PAR1 (F2R), Protease-activated receptor-1, PAR-1, Thrombin receptor, Coagulation factor II receptor, CF2R
    ID gène
    2149
    NCBI Accession
    NM_001992
    UniProt
    P25116
    Pathways
    Nuclear Receptor Transcription Pathway, Skeletal Muscle Fiber Development, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus
Vous êtes ici: